Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

A major rate-limiting step in developing more effective immunotherapies for GBM is our inadequate understanding of the cellular complexity and the molecular heterogeneity of immune infiltrates in gliomas. Here, we report an integrated analysis of 201,986 human glioma, immune, and other stromal cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelfattah, Nourhan, Kumar, Parveen, Wang, Caiyi, Leu, Jia-Shiun, Flynn, William F., Gao, Ruli, Baskin, David S., Pichumani, Kumar, Ijare, Omkar B., Wood, Stephanie L., Powell, Suzanne Z., Haviland, David L., Parker Kerrigan, Brittany C., Lang, Frederick F., Prabhu, Sujit S., Huntoon, Kristin M., Jiang, Wen, Kim, Betty Y. S., George, Joshy, Yun, Kyuson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828877/
https://www.ncbi.nlm.nih.gov/pubmed/35140215
http://dx.doi.org/10.1038/s41467-022-28372-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828877/
https://www.ncbi.nlm.nih.gov/pubmed/35140215
http://dx.doi.org/10.1038/s41467-022-28372-y

Ejemplares similares